Last reviewed · How we verify
Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone Metastasis
A multicenter prospective study to assess the efficacy and safety of ZOMETA® in treatment of high-level NTX non small cell lung cancer with bone metastasis.
Details
| Lead sponsor | Sun Yat-sen University |
|---|---|
| Phase | Phase 4 |
| Status | COMPLETED |
| Enrolment | 156 |
| Start date | 2008-09 |
| Completion | 2013-03 |
Conditions
- Non Small Cell Lung Cancer
- Bone Metastases
- High NTX Level
Interventions
- zometa
Primary outcomes
- Skeleton-related event — 2 years
Countries
China